What’s going on with ALZM?
PennyStocksUniverse Newsletter
Hi Everyone, For our new subscribers, Welcome! Our new medical pick ALZM has been holding steady ground for the last few days, standing very strong towards whatever the shorters and early profit takers are sending its way. By having more of these guys removed from the equation, we could expect a big jump to happen even sooner than anticipated! In fact, the current levels of only $2 seem to be an absolute bargain and a great opportunity for smart investors to capitalize on our fantastic medical pick! ALZM recently announced some very important news:
ALZM has just secured crucial European Patent Rights! The company already holds several patents in the US, South Africa and Australia, and now Europe has been added to the list as well (France, UK, Spain, Netherlands, Germany, Italy, Austria & Belgium)! These patent rights will further strengthen the company`s intellectual property position in the market, and will ensure that no other company steals or benefits from ALZM`s unique and revolutionary technology.
These patent rights will allow ALZM`s Life Cradle brand to to be properly recognized, and let the company make as much profit as possible while saving countless lives all around the world! The company is also expecting to secure patents in other countries as well in the near future.
We`re very excited to see this happen and you should be as well! But that`s not the only good news that we`re excited to share with you today..
ALZM announced that it is already funded for more than $10 Million! This funding allows the company to further clinical trial preparations, and it also opens the floodgates to larger infusions from big investors in the future.
These large investors have so much trust and see so much potential in ALZM that they are funding the company with very large infusions. If they believe in the company so much, shouldn`t you as well In fact, clinical trials normally receive results very quickly. Big announcements could happen very soon; and can you begin to imagine how Wallstreet will react should they get approval by the FDA ALZM could jump over 1000% should it get FDA approval! Everyone appears to be extremely excited about their new revolutionary technology that will be able tosave countless lives once it`s finally available on the market.
ALZM is already up nearly 300% since a few short weeks ago, and we strongly believe that this could just be the beginning of the next big medical gainer! There is a lot of positivity surrounding our pick, and the reason is simple: ALZM HELPS SAVE LIVES! It`s obvious to everyone (and especially to investors) why this is so important, and why any company that helps save lives has the potential to capture unprecedented interest from the markets. Do you seeALZM`s potential Because we sure do, along with countless others! In fact, ALZM is becoming so well established and recognized that its members will be presenting at the International Society for Heart and Lung Transplantation (ISHLT).
All of this great news is shifting a lot of positive attention to our pick, and more and more people are realizing just how much potential it has! Are you one of those people According to smallcapfortunes (most of the information from this point on is quoted):
ALZM could be headed to $20 a share or more.
ALZM will expand the organ transplant market from 21 billion to 60 billion with their patented technology.
ALZM could be the #1 target for a buyout by Johnson&Johnson, Siemens and many more. It`s easy to see why such corporate giants would not hesitate to jump at such an opportunity.
ALZM also announced that they are preparing for clinical trials:
Gene Pearce, who is considered the patriarch of organ transplant in the US, is known to be associated with ALZM. He is the founder and Chairman Emeritus of the United Network for Organ Sharing (UNOS), the quasi-governmental body that regulates organ transplantation in the US and controls the highly restricted wait list. His association should help fast-track FDA approval, which can immediately bring ALZM to new heights.
Very few people know the real reason for the extremely low organ-transplant success rate (a huge problem that our pick can help solve).
This blockbuster investment opportunity starts with this little- known fact:
Currently only 35% of all patients on the `organ transplant waitlist` actually get the organs they need. Considering that many people die waiting, the real success rate is approximately only 12%. This means 88% of people who need a transplant have very little odds of getting one.
But now the Allezoe technology will eventually make it possible to put everybody in need on the waitlist, and then provide up to 80% fulfillment! Do you realize how this remarkable increase could change the lives of those who are on the waitlist Excited We sure are! ALZM could be a fortune-making opportunity for early shareholders.
Just imagine…
Were talking about expanding a $21 billion market to $60 billion, and just one little company has the proven technology to make the whole thing happen! But you may be wondering: Why is the transplant success rate so low Its not so much a shortage of donors (more people are signing up for organ donation all the time). Nor is it a lack of talented surgical teams. Nor even a lack of funding…
The biggest problem is that two-thirds of all donated organs are wasted because of the primitive preservation and transportation technology that damages or kills the organs in transit.
Allezoe Medical solves this problem and it does so with a revolutionary new technology thats a GIANT LEAP forward…
Allezoe`s patented technology can `keep an organ health` in transit for up to 6 times longer than the current standard! Yes, 6 times longer, expanding the current 3 to 4 hour transplant window to 20 to 24 hours. And in many cases, the ALZM system will actually resuscitate and improve the health of the organ in transit.
This ADVANCE will eliminate the tragic 65% wastage, make vastly more healthy organs available for transplant, and significantly reduce costs by removing procurement from an emergency-based system.
When ALZM adds 18 to 22 hours to the transplant viability window, a host of serious problems are eliminated, including…
* Surgeon guesswork regarding the organs health! * Poor donor-to-recipient matches due to short viability time! * High risks added by damaged organs and rushed conditions! * High labor and transport costs due to emergency system! * No time for pre-op testing to help ensure a good outcome! The solution to these problems makes this a life or death decisionliterally! The Life Cradle System has been…
* Developed through 7 generations of prototypes with constant input and feedback from the top organ transplant centers in America and Europe! * Completely tested in 225 preservation experimentsall successful and many producing results beyond anyones wildest expectations! * Proved in both concept and real-life animal studies, with dozens of peer-reviewed articles published in leading medical journals! * Sought out by major medical universities and transplant centers across America and Europe for important studies and the imminent clinical approval trials (on a favored fast-track status)! * And most important to investors… ALZM has insurmountable patent protections (4 issued and 4 pending) as well as the enthusiastic backing of the most important figures in the organ transplant industry.” The Life Cradle System could be used by our military on the battlefield! The Pentagon is excited about the prospects of reattaching limbs lost by soldiers in battle. The Life Cradle System can easily be included in a military units support gear, and the injured soldier and his/her lost limb can be evacuated to the nearest medical facility for surgical repair.
Just look at the facts, do you realize just where ALZM might be headed They possess the technology to save an exponential amount of lives and with the FDA approval they will take the surgical world by storm.
ALZM should be on top of your watch list this week…
We could see fireworks happen very soon! Happy Trading! Your PennyStocksUniverse Editor.
This message was sent to from:
92315563 | 2885 Sanford Ave SW #12529 | GrandVille, MI 49418
Related posts:
- ALZM is funded for 10million
- ALZM is funded for 10million
- Is ALZM a game changer?
- Should you consider ALZM?
- Should you consider ALZM?